Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

Update: 2025-03-21

Description

Sterling Johnson, PhD, Associate Director and Biomarker Core Leader in the Wisconsin Alzheimer’s Disease Research Center (ADRC), and a Clinical Neuropsychologist and Neuroscientist focused on understanding AD-related changes in the brain, details his research into the use of plasma p-tau217 as a blood-based biomarker for detecting Alzheimer disease.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments

In Channel

Beyond Slowing Cognitive Decline: Patient and Caregiver Perspectives on Alzheimer’s Treatment

2025-09-0921:26

Beyond the Boardroom: Barbara Corcoran on Caregiving and Alzheimer Disease

2025-05-0117:42

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

2025-03-2120:59

Updated Criteria for Diagnosis and Staging of Alzheimer Disease: Recommendations of the International Working Group

2025-02-2511:31

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

2025-01-2516:27

The CMS GUIDE Model To Support Patients with Dementia and Their Caregivers

2024-12-1910:42

The BenfoTeam Clinical Trial: Investigating Benfotiamine as a Potential Therapy for Early Alzheimer Disease

2024-11-1915:41

BrainCheck as a Digital Cognitive Assessment Tool

2024-11-0807:17

Kramer, Van Dyck

2024-09-2712:18

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 3

2024-09-2110:14

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 2

2024-09-2117:02

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 1

2024-09-2108:53

Labcorp's Biomarker Testing for Alzheimer Disease

2024-09-1612:50

What Neurologists Should Know About End-of-Life Care Discussions

2024-07-1920:47

Insights into the Role of Tau in Alzheimer Disease and Neurodegenerative Disorders

2024-07-1522:07

Strategies to Limit ARIA Associated with Alzheimer Disease Treatment

2024-07-1509:22

Real-World Implications Beyond Cognition in Treating Alzheimer Disease Patients with Donanemab

2024-07-1508:51

Emerging Therapeutic Targets for Alzheimer Disease

2024-07-1514:27

Progress in Diagnosis and Management of Neuropsychiatric Symptoms in People Living with Dementia

2024-07-0713:05

How Healthcare Providers Can Partner with Caregivers of People Living with Dementia

2024-07-0718:10

00:00

1.0x

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

#box-pro-ellipsis-175981131851548{-webkit-line-clamp:2;}Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

Practical Neurology

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test